Mereo Biopharma Group Plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Mereo Biopharma Group Plc - ADR: Is Infosys Ltd. worth buying?
Item: Mereo Biopharma Group Plc - ADR
Rating: 1.48825
Author: Trendlyne DVM scores

about

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disea...

2.23 -0.01 (-0.45%)

52.75% Fall from 52W High

566.8K

XNAS Volume

XNAS 21 Oct, 2025 12:14 PM (EDT)

Not Eligible

Expensive Valuation

5.0 / 100

Technically Neutral

54.5 / 100

1Yr Price target upside is 238%

8 analysts

Mereo Biopharma Group Plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Mereo Biopharma Group Plc - ADR Live Stock Price Today, Share Analysis and Chart

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disea...

52.75% Fall from 52W High

SWOT Analysis

Mereo Biopharma Group Plc Live Price Chart